CL2020002715A1 - Composiciones y métodos para tratar la endometriosis - Google Patents

Composiciones y métodos para tratar la endometriosis

Info

Publication number
CL2020002715A1
CL2020002715A1 CL2020002715A CL2020002715A CL2020002715A1 CL 2020002715 A1 CL2020002715 A1 CL 2020002715A1 CL 2020002715 A CL2020002715 A CL 2020002715A CL 2020002715 A CL2020002715 A CL 2020002715A CL 2020002715 A1 CL2020002715 A1 CL 2020002715A1
Authority
CL
Chile
Prior art keywords
methods
compositions
treating endometriosis
endometriosis
diagnosis
Prior art date
Application number
CL2020002715A
Other languages
English (en)
Inventor
Kirma Nameer
Nicholson Bruce
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of CL2020002715A1 publication Critical patent/CL2020002715A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966—Animal cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/364—Endometriosis, i.e. non-malignant disorder in which functioning endometrial tissue is present outside the uterine cavity

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)

Abstract

En la presente se describen los métodos para la detección y el diagnóstico de la endometriosis. Más específicamente, se proporcionan métodos de análisis de la expresión de una sola célula sensible para detectar los patrones de expresión génica en poblaciones celulares obtenidos de células endometriales.
CL2020002715A 2018-04-20 2020-10-20 Composiciones y métodos para tratar la endometriosis CL2020002715A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201862660641P 2018-04-20 2018-04-20

Publications (1)

Publication Number Publication Date
CL2020002715A1 true CL2020002715A1 (es) 2021-06-11

Family

ID=68240339

Family Applications (3)

Application Number Title Priority Date Filing Date
CL2020002715A CL2020002715A1 (es) 2018-04-20 2020-10-20 Composiciones y métodos para tratar la endometriosis
CL2023000509A CL2023000509A1 (es) 2018-04-20 2023-02-20 Composiciones y métodos para tratar la endometriosis
CL2024000180A CL2024000180A1 (es) 2018-04-20 2024-01-19 Composiciones y métodos para tratar la endometriosis.

Family Applications After (2)

Application Number Title Priority Date Filing Date
CL2023000509A CL2023000509A1 (es) 2018-04-20 2023-02-20 Composiciones y métodos para tratar la endometriosis
CL2024000180A CL2024000180A1 (es) 2018-04-20 2024-01-19 Composiciones y métodos para tratar la endometriosis.

Country Status (11)

Country Link
US (1) US20210238683A1 (es)
EP (1) EP3781945A4 (es)
JP (2) JP2021521803A (es)
KR (1) KR20210010460A (es)
CN (1) CN112470002A (es)
AU (1) AU2019255402A1 (es)
BR (1) BR112020021372A2 (es)
CA (1) CA3097421A1 (es)
CL (3) CL2020002715A1 (es)
MX (1) MX2020011119A (es)
WO (1) WO2019204803A1 (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113616676B (zh) * 2021-09-09 2022-05-17 青岛大学附属医院 脐血干细胞分泌物在促进子宫内膜细胞生长中的应用
WO2023107375A1 (en) * 2021-12-07 2023-06-15 The Feinstein Institutes For Medical Research Improved methods for detecting and treating endometriosis
KR102677786B1 (ko) * 2021-12-13 2024-06-25 (주)비엠에스 Nrg1 및 smad7 유전자 발현 수준을 이용한 자궁내막증 진단을 위한 정보 제공 방법 및 이를 위한 조성물

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001237178A1 (en) * 2000-02-25 2001-09-03 Metriogene Biosciences Inc. Endometriosis-related markers and uses thereof
EP1537243B1 (en) * 2002-08-30 2008-05-28 Oncotherapy Science, Inc. Method of diagnosing ovarian endometriosis
CA2596932A1 (en) * 2005-02-18 2006-08-31 Ponce School Of Medicine Identification of molecular diagnostic markers for endometriosis in blood lymphocytes
WO2015050875A1 (en) * 2013-10-01 2015-04-09 The Regents Of The University Of California Endometriosis classifier
SG11201708350UA (en) * 2015-04-13 2017-11-29 Univ Johns Hopkins Multiplexed, continuous-flow, droplet-based platform for high-throughput genetic detection
CN105886659A (zh) * 2016-06-29 2016-08-24 北京泱深生物信息技术有限公司 Dstn基因及其表达产物作为子宫内膜癌的诊治靶标
CN106119357B (zh) * 2016-06-29 2019-09-10 北京泱深生物信息技术有限公司 Tns11在制备诊治子宫内膜癌产品中的应用
CN106119358B (zh) * 2016-06-29 2019-08-13 北京泱深生物信息技术有限公司 子宫内膜癌生物标志物的诊治产品

Also Published As

Publication number Publication date
EP3781945A4 (en) 2022-04-27
JP2023099141A (ja) 2023-07-11
BR112020021372A2 (pt) 2021-01-19
KR20210010460A (ko) 2021-01-27
CA3097421A1 (en) 2019-10-24
AU2019255402A1 (en) 2020-11-12
US20210238683A1 (en) 2021-08-05
WO2019204803A1 (en) 2019-10-24
CL2023000509A1 (es) 2023-09-29
CN112470002A (zh) 2021-03-09
CL2024000180A1 (es) 2024-08-16
MX2020011119A (es) 2021-01-29
EP3781945A1 (en) 2021-02-24
JP2021521803A (ja) 2021-08-30

Similar Documents

Publication Publication Date Title
CL2020002715A1 (es) Composiciones y métodos para tratar la endometriosis
BR112017007965A2 (pt) método implantado por computador para inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; aparelho para inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; meio de armazenamento não transitório; programa de computador; kits para medir níveis de expressão de três ou mais genes-alvo da via de sinalização celular de tgf-b em uma amostra de um indivíduo; inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; inferir a atividade de uma via de sinalização celular de tgf-b em um indivíduo; e uso do kit
MX2017015011A (es) Ensayo a base de celulas para detectar homodimeros anti-cd3.
EA201391523A1 (ru) Композиции и способы для переноса энергии митохондрий аутологичных герминативных клеток
BR112017010190A2 (pt) sistema para medição de características, método de medição
BR112017000168A2 (pt) caracterização fenotípica e genotipagem in-situ de uma biblioteca de células geneticamente diferentes
EA201891304A1 (ru) ИНГИБИТОРЫ MAT2A ДЛЯ ЛЕЧЕНИЯ MTAP-null ЗЛОКАЧЕСТВЕННЫХ ОПУХОЛЕЙ
BR112014000965A2 (pt) método, e aparelho
AR102517A1 (es) Ensayos para detectar subgrupos inmunes de células t y sus métodos de uso
GB2522366A (en) Mapping cytosine modifications
CR20130657A (es) Ensayo de lisiloxidasa-homólogo 2 y métodos de uso del mismo
SG195256A1 (en) Alkylamino bodipy dyes as selective fluorescent probes for proteins andmouse embryonic stem cells
WO2020055954A3 (en) Methods for detecting liver diseases
CY1123144T1 (el) Επαγωγη καρδιακης αναγεννησης μe microrna
NZ630583A (en) Method for the rapid determination of susceptibility or resistance of bacteria to antibiotics
CY1120731T1 (el) Θεραπευτικη αγωγη κατα του καρκινου
RS54073B1 (en) STROMAL MATERIAL CELLS
CY1120220T1 (el) Μεθοδοι και κυτια για προσδιορισμο της καταστασης λοιμωξης απο φυματιωση
WO2015189591A3 (en) Method and arrays for use in diagnosing early breast cancer
PH12015501778A1 (en) Markers associated with wnt inhibitors
AR104805A1 (es) Métodos y composiciones para evaluar la capacidad de respuesta de los cánceres a los inhibidores de bet
ES2721477T3 (es) Materiales y métodos para evaluar la progresión del cáncer de próstata
BR112016002709A2 (pt) queratinas como biomarcadores para câncer cervical e sobrevivência
BR112015020054A2 (pt) Método de detectar resistência aos efeitos terapêuticos de um inibidor de akt em uma célula cancerosa
BR112018001256A2 (pt) método de ensaio para avaliação de uma ou mais subclasses de células sanguíneas de interesse (bcoi), método para avaliar a quantidade de receptores de cd4 localizados nas superfícies de células cd4+ e opcionalmente, para avaliar a quantidade de receptores de cd8 localizados nas superfícies de células, dispositivo de ensaio de fluxo vertical para realizar um método, e, uso de um dispositivo.